ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

NCI Seeks $5.799 Billion In FY08 Bypass Budget

November 17, 2006

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

Cooperative Group-cancer control Program To Continue

August 10, 1979